These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25637365)

  • 41. Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe graves' orbitopathy (GO): a prospective, randomized, single-blind clinical trial.
    Moleti M; Violi MA; Montanini D; Trombetta C; Di Bella B; Sturniolo G; Presti S; Alibrandi A; Campennì A; Baldari S; Trimarchi F; Vermiglio F
    J Clin Endocrinol Metab; 2014 May; 99(5):1783-9. PubMed ID: 24432992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Orbital irradiation in the treatment of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Panicucci M; Bogazzi F; Pinchera A
    Bull Soc Belge Ophtalmol; 1988; 226():71-83. PubMed ID: 3151769
    [No Abstract]   [Full Text] [Related]  

  • 43. Selenium in Graves Hyperthyroidism and Orbitopathy.
    Marinò M; Menconi F; Rotondo Dottore G; Leo M; Marcocci C
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S105-S110. PubMed ID: 29933354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of difficult endocrine orbitopathy cases].
    Breuer T; Ammann-Rauch D; Tasman AJ
    Laryngorhinootologie; 2007 May; 86(5):376-81. PubMed ID: 17252323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of oral counselling for smoke cessation in Graves orbitopathy patients.
    de-Arriba-Palomero P; Sales-Sanz M; Fuentemilla E; Won-Kim HR; de-Arriba-Palomero F; Muñoz-Negrete FJ
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jul; 94(7):323-330. PubMed ID: 31036428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Radiation therapy for Graves' ophthalmopathy].
    Misaki T
    Nihon Rinsho; 2006 Dec; 64(12):2287-90. PubMed ID: 17154093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Orbital lymphoma associated with Graves' disease: A case report.
    Hajduković Z; Kuzmić-Janković S; Kljaković-Avramović T; Sekulović L; Tukić L
    Vojnosanit Pregl; 2014 May; 71(5):510-4. PubMed ID: 26137719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
    Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials.
    Banga JP; Nielsen CH; Gilbert JA; El Fassi D; Hegedus L
    Thyroid; 2008 Sep; 18(9):973-81. PubMed ID: 18752425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
    Bartalena L
    J Clin Endocrinol Metab; 2011 Mar; 96(3):592-9. PubMed ID: 21190983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intraorbital pressure measured before, during, and after surgical decompression in Graves' orbitopathy].
    Berthout A; Vignal C; Jacomet PV; Galatoire O; Morax S
    J Fr Ophtalmol; 2010 Nov; 33(9):623-9. PubMed ID: 21047700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of genetics in Graves' disease and thyroid orbitopathy.
    Kim N; Hatton MP
    Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Is radiotherapy beneficial for thyroid ophthalmopathy or not?].
    Prat Partomeu J
    Arch Soc Esp Oftalmol; 2003 Mar; 78(3):131-2. PubMed ID: 12677487
    [No Abstract]   [Full Text] [Related]  

  • 56. [Differential diagnosis of Graves' orbitopathy. Case report].
    Erdei A; Steiber Z; Gazdag A; Bodor M; Berta E; Szász R; Szántó A; Ujhelyi B; Barna S; Berényi E; Nagy VE
    Orv Hetil; 2016 Feb; 157(8):310-5. PubMed ID: 26876268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid-associated orbitopathy: who and how to treat.
    Dickinson J; Perros P
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):373-88, ix. PubMed ID: 19328417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunotherapy for Graves' ophthalmopathy.
    Salvi M
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):409-14. PubMed ID: 25105999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thyroid associated orbitopathy.
    Maheshwari R; Weis E
    Indian J Ophthalmol; 2012; 60(2):87-93. PubMed ID: 22446901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.